FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315433891> ?p ?o ?g. }

• W4315433891 abstract "Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive genetic disorder caused by mutations in the AGXT gene. The hepatic peroxisomal enzyme alanine glyoxylate aminotransferase (AGT) defects encoded by the AGXT gene increase oxalate production, resulting in nephrocalcinosis, nephrolithiasis, chronic kidney disease, and kidney failure. Traditional pharmacological treatments for PH1 are limited. At present, the treatment direction of PH1 is mainly targeted therapy which refer to a method that targeting the liver to block the pathway of the production of oxalate. Lumasiran (OxlumoTM, developed by Alnylam Pharmaceuticals), an investigational RNA interference (RNAi) therapeutic agent, is the first drug approved for the treatment of PH1, which was officially approved by the US Food and Drug Administration and the European Union in November 2020. It is also the only drug that has been shown to decrease harmful oxalate. Currently, there are 5 keys completed and ongoing clinical trials of lumasiran in PH1. Through the three phase III trials that completed the primary analysis period, lumasiran has been shown to be effective in reducing oxalate levels in urine and plasma in different age groups, such as children, adults, and patients with advanced kidney disease, including those on hemodialysis. In addition to clinical trials, cases of lumasiran treatment for PH1 have been reported in small infants, twin infants, and children diagnosed with PH1 after kidney transplantation. These reports confirm the effectiveness and safety of lumasiran. All adverse events were of mild to moderate severity, with the most common being mild, transient injection-site reactions. No deaths or severe adverse events were reported. This article reviews PH1 and lumasiran which is the only approved therapeutic drug, and provide new options and hope for the treatment of PH1." @default.
• W4315433891 created "2023-01-11" @default.
• W4315433891 creator A5048279362 @default.
• W4315433891 creator A5063985740 @default.
• W4315433891 creator A5076529003 @default.
• W4315433891 date "2023-01-10" @default.
• W4315433891 modified "2023-09-30" @default.
• W4315433891 title "Lumasiran for primary hyperoxaluria type 1: What we have learned?" @default.
• W4315433891 cites W2004232118 @default.
• W4315433891 cites W2051158661 @default.
• W4315433891 cites W2064285425 @default.
• W4315433891 cites W2106951882 @default.
• W4315433891 cites W2109644074 @default.
• W4315433891 cites W2136057046 @default.
• W4315433891 cites W2186390246 @default.
• W4315433891 cites W2220036626 @default.
• W4315433891 cites W2328397885 @default.
• W4315433891 cites W2496344419 @default.
• W4315433891 cites W2585731684 @default.
• W4315433891 cites W2591039443 @default.
• W4315433891 cites W2808089905 @default.
• W4315433891 cites W2883629771 @default.
• W4315433891 cites W2898079157 @default.
• W4315433891 cites W2901274586 @default.
• W4315433891 cites W2904166336 @default.
• W4315433891 cites W2909139854 @default.
• W4315433891 cites W2943040154 @default.
• W4315433891 cites W3025216466 @default.
• W4315433891 cites W3034539473 @default.
• W4315433891 cites W3088623630 @default.
• W4315433891 cites W3118921345 @default.
• W4315433891 cites W3122324942 @default.
• W4315433891 cites W3139183760 @default.
• W4315433891 cites W3151149834 @default.
• W4315433891 cites W3162171920 @default.
• W4315433891 cites W3170873706 @default.
• W4315433891 cites W3180537911 @default.
• W4315433891 cites W3213510559 @default.
• W4315433891 cites W4200224342 @default.
• W4315433891 cites W4200495683 @default.
• W4315433891 cites W4205612086 @default.
• W4315433891 cites W4206429797 @default.
• W4315433891 cites W4210775705 @default.
• W4315433891 cites W4213087598 @default.
• W4315433891 cites W4213424500 @default.
• W4315433891 cites W4220954059 @default.
• W4315433891 cites W4226400529 @default.
• W4315433891 cites W4236938577 @default.
• W4315433891 cites W4252938563 @default.
• W4315433891 cites W4283156068 @default.
• W4315433891 cites W4283780634 @default.
• W4315433891 cites W4285403583 @default.
• W4315433891 cites W4289223991 @default.
• W4315433891 cites W4292485487 @default.
• W4315433891 cites W4307585195 @default.
• W4315433891 doi "https://doi.org/10.3389/fped.2022.1052625" @default.
• W4315433891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36704142" @default.
• W4315433891 hasPublicationYear "2023" @default.
• W4315433891 type Work @default.
• W4315433891 citedByCount "1" @default.
• W4315433891 countsByYear W43154338912023 @default.
• W4315433891 crossrefType "journal-article" @default.
• W4315433891 hasAuthorship W4315433891A5048279362 @default.
• W4315433891 hasAuthorship W4315433891A5063985740 @default.
• W4315433891 hasAuthorship W4315433891A5076529003 @default.
• W4315433891 hasBestOaLocation W43154338911 @default.
• W4315433891 hasConcept C126322002 @default.
• W4315433891 hasConcept C165267168 @default.
• W4315433891 hasConcept C197934379 @default.
• W4315433891 hasConcept C2778063415 @default.
• W4315433891 hasConcept C2778653478 @default.
• W4315433891 hasConcept C2780091579 @default.
• W4315433891 hasConcept C2781092957 @default.
• W4315433891 hasConcept C2781145721 @default.
• W4315433891 hasConcept C2911091166 @default.
• W4315433891 hasConcept C535046627 @default.
• W4315433891 hasConcept C62231903 @default.
• W4315433891 hasConcept C71924100 @default.
• W4315433891 hasConcept C98274493 @default.
• W4315433891 hasConceptScore W4315433891C126322002 @default.
• W4315433891 hasConceptScore W4315433891C165267168 @default.
• W4315433891 hasConceptScore W4315433891C197934379 @default.
• W4315433891 hasConceptScore W4315433891C2778063415 @default.
• W4315433891 hasConceptScore W4315433891C2778653478 @default.
• W4315433891 hasConceptScore W4315433891C2780091579 @default.
• W4315433891 hasConceptScore W4315433891C2781092957 @default.
• W4315433891 hasConceptScore W4315433891C2781145721 @default.
• W4315433891 hasConceptScore W4315433891C2911091166 @default.
• W4315433891 hasConceptScore W4315433891C535046627 @default.
• W4315433891 hasConceptScore W4315433891C62231903 @default.
• W4315433891 hasConceptScore W4315433891C71924100 @default.
• W4315433891 hasConceptScore W4315433891C98274493 @default.
• W4315433891 hasLocation W43154338911 @default.
• W4315433891 hasLocation W43154338912 @default.
• W4315433891 hasLocation W43154338913 @default.
• W4315433891 hasOpenAccess W4315433891 @default.
• W4315433891 hasPrimaryLocation W43154338911 @default.
• W4315433891 hasRelatedWork W1971648425 @default.
• W4315433891 hasRelatedWork W1980847881 @default.
• W4315433891 hasRelatedWork W2565576432 @default.

• next